High sensitive C-reactive protein (hsCRP) and neurofilament light (NFL) serum concentrations were assessed at baseline, as they respectively reflect peripheral inflammation and neuronal damage, respectively, and were previously used in MS studies [23,24]. This evidence concerns the gene NEFL and myeloid sarcoma.